Theranexus (EPA:ALTHX) | WebDisclosure

Basculer en Français

10605	Companies
225028	Keywords
153746	Articles
119082	Press releases

Home
Companies
Theranexus

PRESS RELEASE

published on 04/29/2024 at 18:20, 2 years 1 month ago

THERANEXUS PUBLISHES ITS 2023 FULL-YEAR RESULTS AND PRESENTS ITS PROGRESS REPORT
Theranexus reports 2023 financial results, cash position, progress report, and the arrival of Christine Placet as CFO. Highlights include positive Batten-1 trial results and funding options for future trials

Financial Results Theranexus Rare Neurological Diseases Christine Placet Batten-1 Trial
BRIEF

published on 04/29/2024 at 18:05, 2 years 1 month ago

Theranexus annonce ses résultats annuels 2023 et les avancées de ses projets

Biotechnologie Résultats Financiers 2023 Maladies Rares Theranexus Phase De Recherche
BRIEF

published on 04/29/2024 at 18:05, 2 years 1 month ago

Theranexus announces its 2023 annual results and the progress of its projects

Biotechnology 2023 Financial Results Rare Diseases Theranexus Research Phase
PRESS RELEASE

published on 04/29/2024 at 18:00, 2 years 1 month ago

THERANEXUS PUBLIE SES RESULTATS ANNUELS 2023 ET FAIT LE POINT SUR SES ACTIVITÉS
Theranexus, société biopharmaceutique à lyon, publie ses résultats annuels 2023, sa trésorerie 31 mars 2024 et ses activités. Nouvelle Directrice administrative et financière. Projets innovants dans maladies neurologiques rares

Résultats Annuels Trésorerie Theranexus Maladies Neurologiques Rares Christine Placet
BRIEF

published on 04/26/2024 at 18:05, 2 years 1 month ago

Theranexus publie ses informations sur les droits de vote et le capital pour mars 2024

Droits De Vote Capital Social Biopharmaceutique Theranexus Neurologie
BRIEF

published on 04/26/2024 at 18:05, 2 years 1 month ago

Theranexus releases voting rights and capital information for March 2024

Share Capital Voting Rights Biopharmaceutical Neurology Theranexus
PRESS RELEASE

published on 04/26/2024 at 18:00, 2 years 1 month ago

Information mensuelle relative au nombre total de droits de vote et d'actions composant le capital
Theranexus publie le nombre d'actions et de droits de vote au 31 mars 2024, renforçant sa transparence. Détails sur son engagement dans le traitement des maladies neurologiques rares

Droits De Vote Capital Social Biopharmaceutique Theranexus Maladies Neurologiques Rares
BRIEF

published on 04/23/2024 at 07:35, 2 years 1 month ago

Theranexus, Diverchim et l'INSERM obtiennent un financement de 4.7 millions d'euros pour le développement d'un nouvel oligonucléotide antisens

Financement France 2030 Oligonucléotide Antisens Maladies Rares Neurologiques Autophagie Biothérapies
BRIEF

published on 04/23/2024 at 07:35, 2 years 1 month ago

Theranexus, Diverchim and INSERM obtain funding of 4.7 million euros for the development of a new antisense oligonucleotide

Biothérapies France 2030 Funding Antisense Oligonucleotide Rare Neurological Diseases Autophagy
PRESS RELEASE

published on 04/23/2024 at 07:30, 2 years 1 month ago

Theranexus, Diverchim et l'INSERM bénéficient d'un financement de 4.7 millions d'euros dans le cadre de l'appel à projets " Innovations en Biothérapies et Bioproduction " de France 2030, pour développer un nouvel oligonucléotide antisens
Theranexus, Diverchim, and ARNA laboratory of INSERM receive 4.7 million euros from the French government to develop a groundbreaking autophagy activation therapy called PickASO

Theranexus Diverchim ARNA Laboratory Autophagy Activation Therapy PickASO

Accesswire

Published on 06/22/2026 at 03:00, 4 hours 50 minutes ago

Tunkillia Pre-Feasibility Study Begins
Published on 06/20/2026 at 01:00, 2 days 6 hours ago

Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 7 hours ago

Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days 3 hours ago

Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 6 hours ago

American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting

View all ACCESSWIRE

EQS Group

Published on 06/22/2026 at 07:30, 19 minutes ago

NAGRAVISION Launches NAGRA® Venturi, Intelligence-Led Streaming Security for the AI EraTitle
Published on 06/22/2026 at 07:30, 20 minutes ago

Nordex Group secures new US orders totaling 484 MW
Published on 06/22/2026 at 07:00, 50 minutes ago

Sandoz to host capital markets day: maximising Sandoz value in its golden decade for biosimilars
Published on 06/22/2026 at 06:05, 1 hour 44 minutes ago

adidas and GLO Brands B.V., debuts ADIDAS PRO WORK, a new safety footwear range, combining performance, protection and style for the modern worksite
Published on 06/22/2026 at 04:05, 3 hours 44 minutes ago

Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises

Les Echos

Published on 06/19/2026 at 19:33, 2 days 12 hours ago

Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 12 hours ago

Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 12 hours ago

Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 12 hours ago

Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
Published on 06/19/2026 at 19:05, 2 days 12 hours ago

CP - Changement de gouvernance

View all LES ECHOS COMFI WIRE